Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Cancer Chemotherapy and Pharmacology|June 11, 2005
Combination chemotherapy with gemcitabine and biotherapy with opioid growth factor (OGF) enhances the growth inhibition of pancreatic adenocarcinomaIan S Zagon, Jeffrey R Jaglowski, Michael F Verderame, et al.
Digestive Diseases and Sciences|March 8, 2011
Therapy with the opioid antagonist naltrexone promotes mucosal healing in active Crohn's disease: a randomized placebo-controlled trialJill P Smith, Sandra I Bingaman, Francesca Ruggiero, et al.
Cancer Immunology, Immunotherapy : CII|September 25, 2019
Gastrin vaccine improves response to immune checkpoint antibody in murine pancreatic cancer by altering the tumor microenvironmentNicholas Osborne, Rebecca Sundseth, Julian Burks, et al.
Pancreas|December 4, 2014
Distribution of cholecystokinin-B receptor genotype between patients with pancreatic cancer and controls and its impact on survivalJill P Smith, David C Whitcomb, Gail L Matters, et al.
International Journal of Oncology|December 28, 2010
Role of endogenous cholecystokinin on growth of human pancreatic cancerGail L Matters, Christopher McGovern, John F Harms, et al.
Islets|September 14, 2017
Effect of liver histopathology on islet cell engraftment in the model mimicking autologous islet cell transplantationChirag S Desai, Khalid M Khan, Xiaobo Ma, et al.
Molecular Cancer Therapeutics|April 3, 2025
Target-Specific Locked Nucleic Acid Gapmer Decreases Growth and Metastases of Pancreatic CancerJill P Smith, Narayan Shivapurkar, Wenqiang Chen, et al.
Pancreas|October 25, 2013
Pancreatitis-diabetes-pancreatic cancer: summary of an NIDDK-NCI workshopDana K Andersen, Åke Andren-Sandberg, Eric J Duell, et al.
Digestive Diseases and Sciences|May 13, 2014
Cholecystokinin mediates progression and metastasis of pancreatic cancer associated with dietary fatGail L Matters, Timothy K Cooper, Christopher O McGovern, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|January 22, 2024
Implicating the cholecystokinin B receptor in liver stem cell oncogenesisMartha D Gay, Jack C Drda, Wenqiang Chen, et al.
Pageof 7